The Labour manifesto pledged to “maximise our potential to lead the world in clinical trials”. With our regulatory advantage ...
Under Kennedy's plan, the FDA is set to bear the brunt of the job losses, with 3,500 workers due to be shed, while the CDC is ...
Under Kennedy's plan, the FDA is set to bear the brunt of the job losses, with 3,500 workers due to be shed, while the CDC is ...
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...
AstraZeneca has revealed phase 2b results with its oral PCSK9 inhibitor AZD0780, including a more than 50% reduction in ...
The awards ceremony will be held at The Brewery, London, on Thursday 11 th September 2025 where we will host 500+ guests from ...
That is the conclusion of the Advance-HTN study reported at the American College of Cardiology (ACC) meeting, which found ...
At Reuters Pharma USA in Philadelphia, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US ...
EVERSANA is joining more than 20 organisations in Veeva's AI Partner Programme, first launched in April 2024, which provides access to technology and support needed to integrate generative AI (GenAI) ...
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Lilly said it is planning to request a re-examination of the CHMP's appraisal of Kisunla, pointing out that the drug has ...
Last year, surgeons in the US carried out the first transplant of a genetically modified pig kidney into a male subject, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results